![Does a second monovalent SARS-CoV-2 mRNA booster increase neutralizing activity to Omicron variants in nursing home residents and healthcare workers? Does a second monovalent SARS-CoV-2 mRNA booster increase neutralizing activity to Omicron variants in nursing home residents and healthcare workers?](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_737231_16750758699264244.jpg)
Does a second monovalent SARS-CoV-2 mRNA booster increase neutralizing activity to Omicron variants in nursing home residents and healthcare workers?
![COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7104e2_IncidenceDeathRatesOmicron_IMAGE_21Jan22_1200x627.jpg?_=64029)
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR
![Omicron Subvariant Now Dominant in U.S.; FDA, CDC OK Second Booster for Adults Over 50 | The Hospital of Central Connecticut | CT Omicron Subvariant Now Dominant in U.S.; FDA, CDC OK Second Booster for Adults Over 50 | The Hospital of Central Connecticut | CT](https://healthnewshub.org/wp-content/uploads/2022/03/Newsba2OmicronCovid.jpg)
Omicron Subvariant Now Dominant in U.S.; FDA, CDC OK Second Booster for Adults Over 50 | The Hospital of Central Connecticut | CT
![Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/166637/s960_Gov_UK.jpg)
Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK
![Quarta dose contro Covid-19: perché, a chi, quando e con quale vaccino - Network Bibliotecario Sanitario Toscano Quarta dose contro Covid-19: perché, a chi, quando e con quale vaccino - Network Bibliotecario Sanitario Toscano](https://www.mdpi.com/vaccines/vaccines-10-01924/article_deploy/html/images/vaccines-10-01924-g001.png)
Quarta dose contro Covid-19: perché, a chi, quando e con quale vaccino - Network Bibliotecario Sanitario Toscano
![Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01705-6/MediaObjects/41591_2022_1705_Fig1_HTML.png)
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination | Nature Medicine
![Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01832-0/MediaObjects/41591_2022_1832_Fig1_HTML.png)
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
![Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/91d19b8e-2f0b-4e13-8d9b-69e012d37e25/gr1.jpg)
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
![Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant | Communications Medicine Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant | Communications Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs43856-022-00141-4/MediaObjects/43856_2022_141_Fig1_HTML.png)